Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intra-Cellular Therapies Inc (NASDAQ:ITCI)

36.94
Delayed Data
As of May 25
 +0.03 / +0.08%
Today’s Change
21.19
Today|||52-Week Range
60.79
-31.33%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close36.91
Today’s open37.26
Day’s range36.41 - 37.80
Volume307,799
Average volume (3 months)536,349
Market cap$1.6B
Dividend yield--
Data as of 05/25/2016

Growth & Valuation

Earnings growth (last year)-171.96%
Earnings growth (this year)-10.55%
Earnings growth (next 5 years)--
Revenue growth (last year)-84.17%
P/E ratioNM
Price/Sales21,235.50
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Healthcare...+0.49+1.57%
PRTAProthena Corporation...+1.55+3.37%
HCMHutchison China Medi...+0.02+0.16%
TXMDTherapeuticsMD Inc+0.18+2.09%
Data as of 05/25/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$91.4K
Annual profit (last year)-$104.8M
Net profit margin-114,698.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
CFO, Treasurer &
Vice President-Finance
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs